Long-Term Outcomes, Quality of Life, and Kidney Safety Net for PTA Recipients

Purpose of Review Pancreas transplant alone (PTA) is an established treatment for selected patients with brittle diabetes mellitus and preserved kidney function. As perioperative outcomes have improved, attention has shifted toward long-term graft durability, quality of life, and late complications, particularly chronic kidney disease (CKD). This review summarizes contemporary evidence on long-term outcomes after PTA and examines the emerging need for a formal kidney safety net for this population. Recent Findings Recent registry analyses and single-center studies demonstrate durable pancreas graft survival and sustained improvement in glycemic control and quality of life after PTA. However, progressive renal dysfunction remains a significant late complication, even among recipients with acceptable baseline kidney function. Unlike recipients of simultaneous pancreas–kidney or pancreas-after-kidney transplantation, PTA recipients lack a defined allocation pathway or safety net when kidney failure develops. Summary Long-term success after PTA increasingly depends on kidney preservation and equitable access to kidney transplantation. Development of a kidney safety net for PTA recipients warrants renewed consideration to preserve the clinical and quality-of-life benefits of pancreas transplantation.

Authors

Institutions

Publication Details

Journal
Current Transplantation Reports
Published
2026-11-21
DOI
https://doi.org/10.1007/s40472-026-00540-9
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Long-Term Outcomes, Quality of Life, and Kidney Safety Net for PTA Recipients

Erik B. Finger, Michael G. Megaly
Current Transplantation Reports
Renal Transplantation Outcomes and Treatments
article

Long-Term Outcomes, Quality of Life, and Kidney Safety Net for PTA Recipients

Erik B. Finger, Michael G. Megaly
article en

Abstract

Purpose of Review Pancreas transplant alone (PTA) is an established treatment for selected patients with brittle diabetes mellitus and preserved kidney function. As perioperative outcomes have improved, attention has shifted toward long-term graft durability, quality of life, and late complications, particularly chronic kidney disease (CKD). This review summarizes contemporary evidence on long-term outcomes after PTA and examines the emerging need for a formal kidney safety net for this population. Recent Findings Recent registry analyses and single-center studies demonstrate durable pancreas graft survival and sustained improvement in glycemic control and quality of life after PTA. However, progressive renal dysfunction remains a significant late complication, even among recipients with acceptable baseline kidney function. Unlike recipients of simultaneous pancreas–kidney or pancreas-after-kidney transplantation, PTA recipients lack a defined allocation pathway or safety net when kidney failure develops. Summary Long-term success after PTA increasingly depends on kidney preservation and equitable access to kidney transplantation. Development of a kidney safety net for PTA recipients warrants renewed consideration to preserve the clinical and quality-of-life benefits of pancreas transplantation.

Current Transplantation ReportsVol. 13(1)
University of Delaware (US)
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon